Formarse como Médico Oncólogo Radioterápico representa muchos logros profesionales que se resumen en ofrecer cura, bienestar o calidad de vida a muchas personas con cáncer en Panamá y la región.

English, Español, 日本語

• Post-Doctorado Clínico. M.D.Anderson Cancer Center in Houston. 2007
• Especialidad en Braquiterapia de Alta Tasa de Dosis. Instituto Catalán de Oncología. 2006
• Especialidad en Oncología Radioterapica. Tohoku University - Faculty of Medicine, Sendai. 2005
• Especialidad en Radiocirugía. Tohoku University - Faculty of Medicine, Sendai. 2005
• Doctor en Medicina y Cirugía. Universidad Autónoma de Centroamérica (UACA). 1997

• Braquiterapia - Instituto Catalán de Oncología

• Radiocirugía - Centro Docente de Radioterapia GURVE

• Hospital Nacional cod. 156Activo

  Panamá

• Sociedad Panameña de Oncología
• Plan Nacional Contra el Cáncer
• American Society for Therapeutic Radiology and Oncology (ASTRO)
• American Cancer Society (ACS)
• American Association of Physics in Medicine (AAPM)
• American Association of Cancer Research (AACR)

• 2012 SNO Scholarship Award - Sociedad Americana de Neuro-Oncología
• 2006 Junior Investigator Award - Sociedad Japonesa De Radiología (JRS)
• 2006 Berlex-Oncology Clinical Translational Award - MD Anderson Cancer Center

• Director Médico - Centro Internacional de Radiocirugía y Radioterapia Oncológica (CIRRO). Ciudad de Panamá, Panamá
• Vice Presidente - Asociación Nacional Contra el Cáncer (ANCEC)
• Fundador - Centro Internacional de Radiocirugía y Radioterapia Oncológica

• George Starkschall, Ph.D., Peter Balter, Ph.D., Keith Britton, M.D., Ph.D., Mary F. McAleer,M.D., Ph.D., James D. Cox, M.D., and Radhe Mohan, Ph.D. Interfractional reproducibility of lungtumor location using various methods of respiratory motion mitigation. Int J Radiat Onc Biol Phys,Vol: 1;79(2):596-601; Feb 2011.
• Keith R Britton, M.D., Ph.D., George Starkschall, Ph.D., Sandeep Hunjan, PhD., Helen Liu,Ph.D., Joe Y Chang, M.D., Ph.D., Stephen Bilton, CMD, Muthuveni Ezhil, M.D, Sandra John-Baptiste, CMD, Michael Kantor, B.S., James D Cox, M.D., Ritsuko Komaki, M.D. and RadheMohan, Ph.D. Four Dimensional CT Imaging Verification of Target Reproducibility for LungCancer Radiotherapy. Int J Radiat Onc Biol Phys, in revision, 2010.
• Britton K, M.D., Ph.D, Yoshihiro Takai, M.D., Masatoshi Mitsuya, Ph.D., Kenji Nemoto, M.D.,Yoshihiro Ogawa, M.D., and Shogo Yamada, M.D. Image-guided Intensity Modulated RadiationTherapy (IMRT) for prostate cancer: influence of organ motion correction associated with acutetoxicity and Quality Of Life (QOL). Tohoku University Journal, Jul, 2010.
• Keith R. Britton, M.D., Ph.D., George Starkschall, Ph.D., Helen Liu, Ph.D., Joe Y Chang, M.D.,Ph.D., Stephen Bilton, C.M.D., Muthuveni Ezhil, M.D., Sandra John-Baptiste, C.M.D., MichaelKantor, B.S., James D. Cox, M.D., Ritsuko Komaki, M.D., and Radhe Mohan, Ph.D.Consequences of Anatomic Changes and Respiratory Motion on Radiation Dose Distributions inConformal Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. Int J Radiat Onc BiolPhys, Vol 73 (1); 94-102, Jan, 2009.
• Peter Balter, Ph.D., George Starkschall, Ph.D., Keith R. Britton, M.D., Ph.D., Mary F. McAleer, M.D,Ph.D., Radhe Mohan, Ph.D. and James D. Cox, M.D. The 51 st Meeting of the American Society forTherapeutic Radiation Oncology (ASTRO): “Setup Margins for Gated Treatments of Lung Tumors”.Poster presentation; Oct. 31- Nov. 6, 2009, Chicago, USA.
• Keith R. Britton, M.D., Ph.D., George Starkschall, Ph.D., Sandeep Hunjan, Ph.D., Joe Y. Chang, M.D.,Ph.D., Helen Liu, Ph.D., Stephen Bilton, C.M.D., Michael Kantor, B.S., James D. Cox, M.D., RadheMohan, Ph.D. and Ritsuko Komaki, M.D. The 68 th Meeting of Japan Radiological Society (JRS):“Reproducibility of 3-D Conformal Radiation Therapy in Locally Advanced Non-small Cell Lung CancerUsing Four Dimensional CT Imaging”. Oral presentation; Apr. 16-19, 2009, Yokohama, JAPAN.
• Keith R. Britton G., M.D., PhD., Yoshihiro Takai, M.D., Kenji Nemoto, M.D., Yoshihiro Ogawa, M.D.,Masatoshi Mitsuya, Ph.D., Ricardo S. Britton, M.D., and Shogo Yamada, M.D. 1 st InternationalConference on Advances in Radiation Oncology (ICARO): “Image-guided Intensity ModulatedRadiation Therapy (IMRT) for prostate cancer: influence of organ motion correction associated withacute toxicity and Quality Of Life (QOL)”. Poster Discussion Session; Apr. 26-29, 2009 Vienna,AUSTRIA.
• B Rosen, BS, G Starkschall, Ph.D., K Britton, M.D., Ph.D., R Mohan, Ph.D., JD Cox, M.D.Analysis of Intrafractional and Interfractional Variation in Lung Volumes using Four-DimensionalComputed Tomography. Int J Radiat Onc Biol Phys, Vol 72 (issue 1), 288-294, Sept. 2008.
• Soofi W, PhD., Starkschall G, PhD., Britton K, MD., PhD. Vedam S. PhD. Determination of anoptimal organ set to implement deformations to support four-dimensional dose calculations inradiation therapy planning. Journal of Applied Clinical Medical Physics, Vol 9, No. 2, Spring 2008.
• Koto M, MD, Takai Y, MD, Ogawa Y, MD, Matsushita H, MD, Takeda K, MD, Takahashi C, MD,Britton KR, MD, PhD, Jingu K, Takai K, Mitsuya M, Nemoto K, Yamada S. A phase II study onstereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol, vol 85(3),pp. 429-434, Dec., 2007.